EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells


Circulation Research 104(4): 531-540
ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells
Abnormal vascular smooth muscle cell (VSMC) contraction plays an important role in vascular diseases. The RhoA/ROCK signaling pathway is now well recognized to mediate vascular smooth muscle contraction in response to vasoconstrictors by inhibiting myosin phosphatase (MLCP) activity and increasing myosin light chain phosphorylation. Two ROCK isoforms, ROCK1 and ROCK2, are expressed in many tissues, yet the isoform-specific roles of ROCK1 and ROCK2 in vascular smooth muscle and the mechanism of ROCK-mediated regulation of MLCP are not well understood. In this study, ROCK2, but not ROCK1, bound directly to the myosin binding subunit of MLCP, yet both ROCK isoforms regulated MLCP and myosin light chain phosphorylation. Despite that both ROCK1 and ROCK2 regulated MLCP, the ROCK isoforms had distinct and opposing effects on VSMC morphology and ROCK2, but not ROCK1, had a predominant role in VSMC contractility. These data support that although the ROCK isoforms both regulate MLCP and myosin light chain phosphorylation through different mechanisms, they have distinct roles in VSMC function.

(PDF same-day service: $19.90)

Accession: 055338121

PMID: 19131646

DOI: 10.1161/CIRCRESAHA.108.188524



Related references

Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, rho- and rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells. Molecular Pharmacology 71(3): 912-920, 2007

Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells. Molecular Pharmacology 71(3): 912-920, 2006

Myosin phosphatase isoform switching in vascular smooth muscle development. Journal of Molecular and Cellular Cardiology 40(2): 274-282, 2005

Down-regulation of the short isoform of myosin light chain kinase inhibits migration of vascular smooth muscle cells. Molecular Biology of the Cell 13(Supplement): 38a, 2002

Class II phosphoinositide 3-kinase alpha-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle. Biochemical Journal 394(Part 3): 581-592, 2006

Class II phosphoinositide 3-kinase alpha-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle. Biochemical Journal 394(Pt 3): 581-592, 2005

Regulation of myosin isoform expression and cell heterogeneity in the vascular smooth muscle. European Journal of Cell Biology Supplement (35): 39, 1991

Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells. American Journal of Physiology. Cell Physiology 303(1): C58-C68, 2012

Developmental regulation of vascular smooth muscle myosin heavy chain isoform expression. Japanese Circulation Journal 54(7): 714, 1990

Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. Journal of Biological Chemistry 275(14): 9897-9900, 2000